TrialBritish journal of clinical pharmacology2013

Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor.

Gretchen Bain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.